Morcos S K
Department of Diagnostic Imaging, Northern General Hospital, Sheffield S5 7AU, UK.
Clin Radiol. 2009 May;64(5):468-72. doi: 10.1016/j.crad.2008.08.019. Epub 2008 Dec 25.
It is acknowledged that high osmolar contrast media are more nephrotoxic than low (LOCM) or iso-osmolar contrast media (IOCM). However, it remains contentious whether the IOCM are less nephrotoxic in comparison with LOCM. This article reviews published clinical studies that investigated this issue and demonstrates there are no conclusive data to indicate that there is a definite difference in renal tolerance between LOCM and IOCM. All these agents are potentially nephrotoxic in patients with advanced renal impairment. In these patients the smallest possible dose of IOCM or LOCM should be used in addition to adequate hydration to minimize the risk of contrast nephropathy.
公认的是,高渗性对比剂比低渗性(LOCM)或等渗性对比剂(IOCM)具有更强的肾毒性。然而,与低渗性对比剂相比,等渗性对比剂的肾毒性是否更低仍存在争议。本文回顾了已发表的针对该问题的临床研究,并表明没有确凿数据表明低渗性对比剂和等渗性对比剂在肾脏耐受性方面存在明确差异。所有这些药物对晚期肾功能损害患者都有潜在的肾毒性。在这些患者中,除了充分水化外,应使用最小可能剂量的等渗性对比剂或低渗性对比剂,以将对比剂肾病的风险降至最低。